Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1274

1.

Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.

Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL.

J Am Coll Cardiol. 2013 Oct 29;62(18):1674-9. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.

2.

Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.

Roses-Noguer F, Jarman JW, Clague JR, Till J.

Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.

PMID:
24120999
3.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.

4.

Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).

Ruwald MH, Abu-Zeitone A, Jons C, Ruwald AC, McNitt S, Kutyifa V, Zareba W, Moss AJ.

J Am Coll Cardiol. 2013 Oct 8;62(15):1343-50. doi: 10.1016/j.jacc.2013.03.087. Epub 2013 Jun 13.

5.

Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.

Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M.

Europace. 2012 Feb;14(2):224-9. doi: 10.1093/europace/eur307. Epub 2011 Sep 22.

PMID:
21946820
6.

Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.

Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, McNitt S, Jons C, Moss AJ, Zareba W.

Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9.

7.

Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.

Saxon LA, Greenfield RA, Crandall BG, Nydegger CC, Orlov M, VAN Genderen R.

J Cardiovasc Electrophysiol. 2006 May;17(5):520-5.

PMID:
16684026
8.

Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.

Miyake CY, Webster G, Czosek RJ, Kantoch MJ, Dubin AM, Avasarala K, Atallah J.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):579-87. doi: 10.1161/CIRCEP.113.000170. Epub 2013 May 11.

9.

Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

Aktas MK, Goldenberg I, Moss AJ, Huang DT, Kutyifa V, Wang PJ, Brenyo A, McNitt S, Zareba W, Barsheshet A.

Am J Cardiol. 2014 Dec 15;114(12):1855-60. doi: 10.1016/j.amjcard.2014.09.026. Epub 2014 Sep 28.

PMID:
25438913
10.

Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.

Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH.

J Heart Lung Transplant. 2010 Jul;29(7):771-6. doi: 10.1016/j.healun.2010.02.001. Epub 2010 Mar 29.

PMID:
20347337
11.

Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.

Ruwald MH, Zareba W, Jons C, Zhang C, Ruwald AC, Olshansky B, McNitt S, Bloch Thomsen PE, Shoda M, Merkely B, Moss AJ, Kutyifa V.

Circulation. 2013 Aug 13;128(7):694-701. doi: 10.1161/CIRCULATIONAHA.113.002472. Epub 2013 Jul 23.

12.

Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.

Theuns D, Klootwijk AP, Kimman GP, Szili-Török T, Roelandt JR, Jordaens L.

Europace. 2001 Jul;3(3):181-6.

PMID:
11467458
13.

Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.

Kutyifa V, Bloch Thomsen PE, Huang DT, Rosero S, Tompkins C, Jons C, McNitt S, Polonsky B, Shah A, Merkely B, Solomon SD, Moss AJ, Zareba W, Klein HU.

Heart Rhythm. 2013 Dec;10(12):1770-7. doi: 10.1016/j.hrthm.2013.08.020. Epub 2013 Aug 22.

PMID:
23973954
14.

The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.

Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL.

Heart Rhythm. 2012 Jan;9(1):24-31. doi: 10.1016/j.hrthm.2011.08.005. Epub 2011 Aug 9.

PMID:
21835150
15.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators.

J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073.

16.

Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.

J Am Coll Cardiol. 2013 Nov 19;62(21):2000-7. doi: 10.1016/j.jacc.2013.05.086. Epub 2013 Jul 31.

17.

Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.

Ricci RP, Pignalberi C, Landolina M, Santini M, Lunati M, Boriani G, Proclemer A, Facchin D, Catanzariti D, Morani G, Gulizia M, Mangoni L, Grammatico A, Gasparini M; ClinicalService cardiological centres.

Heart. 2014 Jun;100(11):848-54. doi: 10.1136/heartjnl-2013-305259. Epub 2014 Mar 28.

PMID:
24682569
18.

Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.

PMID:
16255753
19.

Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.

Grimm W, Flores BF, Marchlinski FE.

Pacing Clin Electrophysiol. 1992 Nov;15(11 Pt 1):1667-73.

PMID:
1279533
20.

Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators.

Love BA, Barrett KS, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK, Walsh EP, Berul CI.

J Cardiovasc Electrophysiol. 2001 Oct;12(10):1097-101.

PMID:
11699514

Supplemental Content

Support Center